Get my own profile
Public access
View all19 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Johan LundinMD, PhD, Research Director, FIMM, University of Helsinki and Professor, Karolinska InstitutetVerified email at helsinki.fi
- Dmitrii BychkovKaliber Labs | University of HelsinkiVerified email at helsinki.fi
- Satu MustjokiUniversity of HelsinkiVerified email at helsinki.fi
- Lassi PaavolainenInstitute for Molecular Medicine Finland (FIMM), University of HelsinkiVerified email at fimm.fi
- Magnus JaderbergOncos TherapeuticsVerified email at oncos.com
- Anniina Koskikokeellisen onkologian dosentti, Helsingin YliopistoVerified email at hus.fi
- Matti PietikäinenProfessor, University of OuluVerified email at oulu.fi
- Esa RahtuProfessor, Tampere University, FinlandVerified email at tuni.fi
- Yinhai WangData Sciences & Quantitative Biology, AstraZenecaVerified email at astrazeneca.com
- Päivi ÖstlingScientific Lead of Precision Medicine, SciLifeLab, Dept. Oncology and Pathology, KarolinskaVerified email at ki.se
- Timo AhonenSoftware Engineering Manager at MetaVerified email at fb.com
- Elina ParriDoctoral Student, Institute for Molecular Medicine Finland (FIMM)Verified email at helsinki.fi
- Khalid SaeedCancer Research UK, Cambridge CentreVerified email at cancer.org.uk
- Tauno MetsaluUniveristy of TartuVerified email at ut.ee
- Emma J DaviesAstraZenecaVerified email at astrazeneca.com
- Juan Delgado-SanMartinWunderman ThompsonVerified email at wundermanthompson.com
- Simon AndersBioquant Center, University of HeidelbergVerified email at fs.tum.de
- Tero AittokallioUniversity of Helsinki, University of Turku, University of OsloVerified email at utu.fi
- vincenzo CerulloProfessor Biological Drugs, University of HelsinkiVerified email at helsinki.fi
- Samuli Eldfors, PhDResearch Fellow, MGH, Harvard Medical SchoolVerified email at mgh.harvard.edu